Search Results - "Delgado, Juan Ramon"

ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients by Martínez-Galán, Joaquina, Torres-Torres, Blanca, Núñez, María Isabel, López-Peñalver, Jesús, Del Moral, Rosario, Ruiz De Almodóvar, José Mariano, Menjón, Salomón, Concha, Angel, Chamorro, Clara, Ríos, Sandra, Delgado, Juan Ramón

“…Tumor expression of estrogen receptor (ER) is an important marker of prognosis, and is predictive of response to endocrine therapy in breast cancer. Several…”
Get full text

Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients by Pérez-Ramírez, Cristina, Cañadas-Garre, Marisa, Alnatsha, Ahmed, Villar, Eduardo, Delgado, Juan Ramón, Faus-Dáder, María José, Calleja-Hernández, Miguel ÿngel

“…[Display omitted] Platinum-based chemotherapy is the standard treatment for NSCLC patients with EGFR wild-type, and as alternative to failure to EGFR…”
Get full text

The Polemic Diagnostic Role of TP53 Mutations in Liquid Biopsies from Breast, Colon and Lung Cancers by Garrido-Navas, M. Carmen, García-Díaz, Abel, Molina-Vallejo, Maria Pilar, González-Martínez, Coral, Alcaide Lucena, Miriam, Cañas-García, Inés, Bayarri, Clara, Delgado, Juan Ramón, González, Encarna, Lorente, Jose Antonio, Serrano, M. Jose

“…Being minimally invasive and thus allowing repeated measures over time, liquid biopsies are taking over traditional solid biopsies in certain circumstances…”
Get full text

Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer by Pérez-Ramírez, Cristina, Cañadas-Garre, Marisa, Alnatsha, Ahmed, Molina, Miguel Ángel, Robles, Ana I, Villar, Eduardo, Delgado, Juan Ramón, Faus-Dáder, María José, Calleja-Hernández, Miguel Ángel

“…Abstract Background Surgery is the standard treatment for early-stage NSCLC, and platinum-based chemotherapy remains as the treatment of choice for…”
Get full text

Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer by Pérez-Ramírez, Cristina, Cañadas-Garre, Marisa, Alnatsha, Ahmed, Villar, Eduardo, Delgado, Juan Ramón, Calleja-Hernández, Miguel Ángel, Faus-Dáder, María José

“…Lung cancer, particularly non-small cell lung cancer (NSCLC) subtype, is the leading cause of cancer-related death related worldwide. Numerous gene…”
Get full text

Interplay Between Gemcitabine and Erlotinib Over Pancreatic Adenocarcinoma Cells by Torres, Carolina, Linares, Ana, Alejandre, Maria Jose, Palomino-Morales, Rogelio Jesus, Delgado, Juan Ramon, Perales, Sonia

“…Pancreatic ductal adenocarcinoma remains as a chemoresistant disease with the poorest prognosis. Gemcitabine has been the standard treatment during the last…”
Get full text

Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years by Provencio, Mariano, Franco, Fernando, Gómez-Codina, José, Quero Blanco, Cristina, Llanos, Marta, Garcia-Arroyo, Francisco, de la Cruz, Luis, Gumá, Josep, Delgado, Juan Ramón, Álvarez, Ruth, Chacón, José Ignacio, Royuela, Ana, Rueda, Antonio

Get full text

High serum levels of vascular endothelial growth factor-C have a positive impact on outcome of patients with advanced diffuse large B cell lymphoma by Rueda, Antonio, Rifá, Julio, Quero, Cristina, Gómez-Codina, José, Murias, Adolfo, García-Arroyo, Francisco Ramón, Sabín, Pilar, Llanos, Marta, Herrero, Joaquin, Lobo, Francisco, Delgado, Juan Ramón, Provencio, Mariano

Get full text

Biochemotherapy in the treatment of metastatic melanoma in selected patients by González Astorga, Beatriz, Jiménez Rubiano, Berta, Delgado Pérez, Juan Ramón, Valdivia Bautista, Javier, Sánchez Toro, Carmen, González Flores, Encarnación, Luque Caro, Raquel, Castellón Rubio, Victoria

“…Introduction Bioimmunochemotherapy (BCT) is a combination of biological agents and cytostatics that has shown an increase in response rate (RR) in metastatic…”
Get full text

Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain? by Provencio, Mariano, Sabín, Pilar, Gómez Codina, José, Rueda, Antonio, Llanos, Marta, Gumá, Josep, Quero Blanco, Cristina, Blasco, Ana, Delgado, Juan Ramón, Cruz, Miguel Ángel, Aguiar, David, García-Arroyo, Francisco Ramón, Herrero, Joaquín, Lavernia, Javier, Martínez Banaclocha, Natividad, Morales, Manuel, Fuster, José, Sáez Cusi, Álvaro, Lobo, Francisco, Rodríguez Abreu, Delvys, de la Cruz, Luis, Antón, Edelmira, Rodríguez Jiménez, Alberto, Arízcun, Alberto, Pérez, Xavi

“…Introduction Little data is available concerning variations in the clinical characteristics of lymphoid neoplasms at presentation. We decided to investigate…”
Get full text

Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues by Muros, María Angustias, Varsavsky, Mariela, Iglesias Rozas, Pablo, Valdivia, Javier, Delgado, Juan Ramón, Forrer, Flavio, Bodei, Lisa, Paganelli, Giovanni

“…Objectives To evaluate the initial response and outcomes (quality of life and presence of side effects) in patients with advanced neuroendocrine tumours (NET)…”
Get full text

The potential role of the glycoprotein osteoactivin/glycoprotein nonmetastatic melanoma protein B in pancreatic cancer by Torres, Carolina, Linares, Ana, Alejandre, Maria Jose, Palomino-Morales, Rogelio, Martin, Miguel, Delgado, Juan Ramon, Martinez, Joquina, Perales, Sonia

“…Pancreatic ductal adenocarcinoma is still one of the deadliest solid cancers so the finding of new therapeutic approaches and novel targets are of utmost…”
Get full text

Abstract A126: Change in status promoter of 5 panel gene during progression of atypical hyperplasia to breast cancer by Joaquina, Martínez-Galán, Delgado, Juan Ramon, Torres-Torres, Blanca, Del Moral, Rosario, Ríos, Sandra, Núñez, M. Isabel

“…Abstract Background: DNA methylation is the main epigenetic modification in cancer. The pathological features of breast cancer follow a sequential progression…”
Get full text

Epigenetic aspects of triple-negative in patients with breast cancer by Martínez-Galan, Joaquina, Rios, Sandra, Delgado, Juan Ramon, Torres-Torres, Blanca, Lopez-Peñalver, Jesus, Núñez, M. Isabel

“…Abstract only 1041 Background: Identification of gene expression-based breast cancer subtypes is considered a critical means of prognostication. Genetic…”
Get full text

Significance and clinical outcome of lymph node level assessment in biliary tract cancers by Martínez-Galán, Joaquina, Soberino, Jesús, González Rivas, Cynthia S., Ruiz Vozmediano, Julia, Portellano, Lucia, Conde, Veronica, Ortega, Jose Antonio, Garcia, Javier, González Vicente, Aranzazu, Delgado, Juan Ramon

“…Abstract only 274 Background: Biliary tract cancers (BTCs) are relatively rare neoplasms encompass both cholangiocarcinoma (CC).The role of routine…”
Get full text

MDR1 gene expression in peripheral blood as a marker of treatment response in lung cancer by Luque, Raquel, Gonzalez Flores, Encarnacion, Delgado, Juan Ramon, Melguizo, Consolación, Prados, Jose Carlos, Gonzalez Astorga, Beatriz, Ortiz, Raul, Sánchez Toro, Carmen, Valdivia, Javier, Aránega, Antonia

“…Abstract only 96 Background: Non-small cell lung cancer (NSCLC) is sometimes chemoresistant and does not respond to treatment; several factors are involved in…”
Get full text

Abstract B09: PROMOTER CPG ISLAND METHYLATION DURING PROGRESSION OF ATYPICAL HYPERPLASIA TO BREAST CANCER by Martinez-Galan, Joaquina, Delgado, Juan Ramon, Moral, Rosario Del, Torres-Torres, Blanca

“…Abstract DNA methylation is the main epigenetic modification in cancer. The pathological features of breast cancer follow a sequential progression from…”
Get full text

Abstract A67: Methylation of ESR1 and 14-3-3 sigma promoter in serum as possible biomarkers for screening and diagnosis for breast cancer by Martinez-Galan, Joaquina, Torres-Torres, Blanca, Delgado, Juan Ramón

“…Abstract Background: To investigate the association between gene hypermethylation and the major clinico-pathological features of breast cancer, including…”
Get full text

90 yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: Updated results after a median follow-up of 8.5 years from the GOTEL trial by Provencio-Pulla, Mariano, Franco, Fernando, Gómez-Codina, Jose, Quero, Cristina, Llanos, Marta, Garcia Arroyo, Francisco Ramon, De la Cruz-Merino, Luis, Guma, Josep, Delgado, Juan Ramón, Alvarez, Ruth, Chacon, Jose Ignacio, Royuela, Ana, Rueda, Antonio

“…Abstract only…”
Get full text

Methylation ESR1 as a potential factor of resistence to HER2/neu therapy in patients with breast cancer by Martínez-Galán, Joaquina, González Rivas, Cynthia S., Ruiz Vozmediano, Julia, Portellano, Lucia, Delgado, Juan Ramón

“…Abstract only 24 Background: Estrogen receptor (ER)-positive breast cancers are considered prognostically more favorable than ER-negative tumors and are often…”
Get full text